In the past decade, a single strain of Escherichia coli, or E. coli, has become the main cause of bacterial infections in women and the elderly by invading the bladder and kidneys, according to a study published today in ...
Dec 17, 2013
0
0
New research, to be published in the Journal of Clinical Psychiatry, finds that men who developed persistent sexual side effects while on finasteride (Propecia), a drug commonly used for male pattern hair loss, have a high ...
Aug 7, 2012
0
1
In the United States, African Americans have approximately twice the risk of end-stage renal disease compared to white Americans, despite a similar prevalence in earlier stages of chronic kidney disease. A large study co-authored ...
Nov 26, 2013
0
0
As food consumed in the U.S. becomes more and more processed, obesity may become more prevalent. Through reviewing overall trends in food, George Washington University (GW) researcher Leigh A. Frame, Ph.D., MHS, concluded ...
Jan 6, 2020
0
2
A new combination drug treatment has shown promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
Mar 28, 2023
0
2
When Anna Markowitz learned that George Washington University researchers were looking for healthy volunteers to infect with bloodthirsty hookworms, her decision was resolute.
Jul 7, 2015
0
94
Policy and environmental changes are very important in preventing unhealthy weight gain but may not help people with severe obesity achieve substantial weight loss, according to a report published online February 18 in The ...
Feb 18, 2015
1
21
If it were as easy as the movies depict, studying for final exams would be a three-minute montage of library visits and late-night study sessions set to pop music, but in the real world students often find themselves surrounded ...
Dec 10, 2013
0
0
A 2012 law that loosened conflict-of-interest restrictions for FDA advisory panels could weaken the agency's review system and could allow more drugs with safety problems to gain market approval, says a new analysis published ...
Jun 6, 2013
4
0
Two phase 3 trials suggest that a 16 week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis, according to a paper published in the New England Journal of ...
Mar 15, 2023
0
23
